Evidence map›Paper›PMID 22426390›Full record

ReviewNeurobiology of disease2012

Brain, blood, and iron: perspectives on the roles of erythrocytes and iron in neurodegeneration.

Rainer Prohaska, Ody C M Sibon, Dobrila D Rudnicki, Adrian Danek, Susan J Hayflick, Esther M Verhaag, Jan J Vonk, Russell L Margolis, Ruth H Walker

Open access · greenAbstract readReview
In one paragraph

Review in Neurobiology of disease, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Acanthocytes Identified in Huntington's Disease.Frontiers in neuroscience · 2022
    Article
  7. PKAN neurodegeneration and residual PANK2 activities in patient erythrocytes.Annals of clinical and translational neurology · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2015
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Diagnosis and treatment of chorea syndromes.Current neurology and neuroscience reports · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 4 countries.

Rainer ProhaskaMax F Perutz Laboratories, Medical University of Vienna, Vienna, Austria.
Ody C M Sibon
Dobrila D Rudnicki
Adrian Danek
Susan J Hayflick
Esther M Verhaag
Jan J Vonk
Russell L Margolis
Ruth H Walker
University of Groningen · NLJohns Hopkins University · USIcahn School of Medicine at Mount Sinai · USLudwig-Maximilians-Universität München · DEMedical University of Vienna · ATOregon Health & Science University · US

Funding

RNA mediated Neurotoxicity in Huntington's Disease-Like 2 and Huntington DiseaseR01NS064138 · NINDS · JOHNS HOPKINS UNIVERSITY · PI RUDNICKI, DOBRILA DODA · 2009 to 2013
$1.8M
Brain, Blood, and Iron: advances in the cell biology of neurodegenerationR13NS067922 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WALKER, RUTH HELEN · 2010 to 2010
$33k
Austrian Science Fund FWF I 438NINDS NIH HHS 1R13NS067922-01NINDS NIH HHS R01 NS064138NINDS NIH HHS R13 NS067922
6 · The paper itself

Abstract

The terms "neuroacanthocytosis" (NA) and "neurodegeneration with brain iron accumulation" (NBIA) both refer to groups of genetically heterogeneous disorders, classified together due to similarities of their phenotypic or pathological findings. Even collectively, the disorders that comprise these sets are exceedingly rare and challenging to study. The NBIA disorders are defined by their appearance on brain magnetic resonance imaging, with iron deposition in the basal ganglia. Clinical features vary, but most include a movement disorder. New causative genes are being rapidly identified; however, the mechanisms by which mutations cause iron accumulation and neurodegeneration are not well understood. NA syndromes are also characterized by a progressive movement disorder, accompanied by cognitive and psychiatric features, resulting from mutations in a number of genes whose roles are also basically unknown. An overlapping feature of the two groups, NBIA and NA, is the occurrence of acanthocytes, spiky red cells with a poorly-understood membrane dysfunction. In this review we summarise recent developments in this field, specifically insights into cellular mechanisms and from animal models. Cell membrane research may shed light upon the significance of the erythrocyte abnormality, and upon possible connections between the two sets of disorders. Shared pathophysiologic mechanisms may lead to progress in the understanding of other types of neurodegeneration.

Indexed as

AnimalsAutophagyBrainBrain ChemistryErythrocytesHumansIronNeuroacanthocytosisNeurodegenerative DiseasesIron

Identifiers

PMID22426390
PMCPMC3352961
OpenAlexW2029703586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.